This compound is a steroidal pharmaceutical intermediate characterized by a tetracyclic ring system and multiple chiral centers. Its primary significance lies in its use as a building block for the synthesis of specialized steroid derivatives.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Procurando comprar este composto?
Publique um pedido de compra gratuito, sem necessidade de conta. Ele chega aos fornecedores deste produto e as respostas vão direto para o seu e-mail.
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
(R)-4-((3R,5S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINE
pharmaceutical intermediate
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
Pharmaceutical intermediate for lurasidone
3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (10-phenylanthracen-9-yl)boronate
synthetic intermediate for boron-containing compounds
1,1,1-Trifluoro-4-iodobutane
Pharmaceutical intermediate
3alpha-Hydroxy-7-oxo-5beta-cholan-24-oic acid methyl ester
bile acid intermediate for drug synthesis
7-Ketolithocholic acid
bile acid intermediate
ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
PRZCLWHVOYRZJL-GAKWKJAJSA-N
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1=O)CC[C@@H]4[C@H](C)CCC(=O)OCC)C)C)O
—
Procurando comprar este composto?
Publique um pedido de compra gratuito, sem necessidade de conta. Ele chega aos fornecedores deste produto e as respostas vão direto para o seu e-mail.